A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza - Trial 2016-003003-54
Access comprehensive clinical trial information for 2016-003003-54 through Pure Global AI's free database. This phase not specified trial is sponsored by F. Hoffmann-La Roche AG and is currently status unknown. The study focuses on Influenza.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2016-003003-54
Trial Details
EU Clinical Trials Register • 2016-003003-54
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
Study Focus
Sponsor & Location
F. Hoffmann-La Roche AG
Hoffmann-La Roche
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Steady-state pharmacokinetics parameters AUC0-12 and Cmax of oseltamivir and oseltamivir carboxylate
ICD-10 Classifications
Influenza and pneumonia
Influenza due to identified seasonal influenza virus
Influenza with other manifestations, seasonal influenza virus identified
Influenza with pneumonia, seasonal influenza virus identified
Influenza due to identified zoonotic or pandemic influenza virus
Data Source
EU Clinical Trials Register
2016-003003-54
Non-Device Trial